Investigating the Frequency of Resistance to Activated Protein C and Protein S, C and Antithrombin Deficiencies in Patients with Deep Vein Thrombosis Referred to the Iranian Blood Transfusion Organization

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 226

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ZUMS-25-112_003

تاریخ نمایه سازی: 11 اردیبهشت 1400

Abstract:

Background and Objective: Deep vein thrombosis (DVT) is one of the most common forms of venous thromboembolism (VTE). Deficiency in natural anticoagulant proteins is considered to be the major cause of thrombosis. In the present study, we investigated the incidence of defects in protein S, protein C, antithrombin and resistance to activated protein C (APC-R) in patients with DVT referred to the Iranian Blood Transfusion Organization (IBTO). Results were compared with findings from other studies performed in the other nations. Materials and Methods: In this descriptive study, a total of ۶۵۶ patients with DVT were evaluated for the deficiency of natural anticoagulant proteins, including protein S, C, antithrombin and APC-R. After eliminating patients with acquired risk factors for thrombosis, defects in the aforementioned proteins were examined in ۱۴۱ cases. The results were compared with the results of other studies using the Z score calculation. Results: Protein S deficiency with ۱۲.۷% of cases was the most prevalent defect in our study. A defect in APC-R, which was found in ۴.۹ percent of cases, was the second prevalent deficiency. Moreover, AT and PC deficiencies with a prevalence rate of ۲.۸ and ۲.۱%, had the lowest rate in patients with DVT, respectively. Conclusion: Protein S deficiency was the most common anticoagulant protein deficiency in patients with DVT referred to IBTO. The results obtained in this study are in concordance with the studies conducted in Middle East and other Asian countries. However, significant differences between our results and findings from studies performed in western nations exist. 

Keywords:

Key words: Anticoagulant proteins , Deep Vein Thrombosis , Venous thromboembolism

Authors

زینال سلمانپور

Dept. of Hematology and Blood Banking, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مینو احمدی نژاد

Iranian Blood Transfusion Organization Research Center, Tehran, Iran

داود بشاش

Dept. of Hematology and Blood Banking, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

محسن حمیدپور

Dept. of Hematology and Blood Banking, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

سیما ذوالفقاری

Iranian Blood Transfusion Organization Research Center, Tehran, Iran

فرزانه احمدی

Dept. of Biostatistic, Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • References1 -Khan S, Dickerman D. Hereditary thrombophilia. Thrombosis Journal, 2006. ...
  • Bhuiyan, FR, Effect of isoflavones on serum homocysteine and c-reactive ...
  • Rosendaal, F.R, Venous thrombosis: the role of genes, environment, and ...
  • Egesel, T, The role of natural anticoagulant deficiencies and factor ...
  • 5 -Bovill, EG. The clinical spectrum of heterozygous protein C ...
  • Goldenberg N, Manco-Johnson J. Protein C deficiency. Haemophilia, 2008. 14: ...
  • 7 -Vossen C. Risk of a first venous thrombotic event ...
  • Sajjadieh MRS, Viunytska LV. Antithrombin-III as a non-invasive marker of ...
  • Johnston A. Use of a functional assay to diagnose protein ...
  • Marlar RA, Potts RM,. Welsh CH. Accuracy of diagnosis of ...
  • Dahlback B. The tale of protein S and C4b-binding protein, ...
  • Heijboer H. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients ...
  • Gessoni G. Laboratory assessment of hypercoagulable state. A study in ...
  • Marlar RA, Gausman JN. Protein S abnormalities: a diagnostic nightmare. ...
  • GĂMAN AM. Găman G. Deficiency of antithrombin III (AT III)-case ...
  • Suehisa A. Frequency of natural coagulation inhibitor (antithrombin III, protein ...
  • Al-Jaouni SK. Primary thrombophilia in Saudi Arabia. Saudi Med J, ...
  • Marouf R. Plasma homocysteine and hematological factors in patients with ...
  • Yilmaz S , Gunaydin S. Inherited risk factors in low-risk ...
  • Rosendaal F. High risk of thrombosis in patients homozygous for ...
  • Perry SL, Ortel TL. Clinical and laboratory evaluation of thrombophilia. ...
  • Miljić P. Hereditary deficiency of antithrombin III, protein C, protein ...
  • نمایش کامل مراجع